Medpace Holdings Price to Book Ratio 2014-2024 | MEDP
Historical price to book ratio values for Medpace Holdings (MEDP) over the last 10 years. The current price to book ratio for Medpace Holdings as of December 20, 2024 is 11.82.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Medpace Holdings Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-12-20 | 337.28 | 11.89 | |
| 2024-09-30 | 333.80 | $28.36 | 11.77 |
| 2024-06-30 | 411.85 | $24.63 | 16.72 |
| 2024-03-31 | 404.15 | $21.67 | 18.65 |
| 2023-12-31 | 306.53 | $18.18 | 16.86 |
| 2023-09-30 | 242.13 | $15.35 | 15.78 |
| 2023-06-30 | 240.17 | $12.80 | 18.77 |
| 2023-03-31 | 188.05 | $11.34 | 16.58 |
| 2022-12-31 | 212.41 | $12.43 | 17.09 |
| 2022-09-30 | 157.17 | $11.25 | 13.97 |
| 2022-06-30 | 149.67 | $9.14 | 16.37 |
| 2022-03-31 | 163.59 | $17.98 | 9.10 |
| 2021-12-31 | 217.64 | $26.47 | 8.22 |
| 2021-09-30 | 189.28 | $24.99 | 7.57 |
| 2021-06-30 | 176.63 | $23.78 | 7.43 |
| 2021-03-31 | 164.05 | $23.91 | 6.86 |
| 2020-12-31 | 139.20 | $22.69 | 6.14 |
| 2020-09-30 | 111.75 | $22.14 | 5.05 |
| 2020-06-30 | 93.02 | $20.84 | 4.46 |
| 2020-03-31 | 73.38 | $20.23 | 3.63 |
| 2019-12-31 | 84.06 | $20.14 | 4.17 |
| 2019-09-30 | 84.04 | $19.22 | 4.37 |
| 2019-06-30 | 65.42 | $18.33 | 3.57 |
| 2019-03-31 | 58.97 | $17.41 | 3.39 |
| 2018-12-31 | 52.93 | $16.53 | 3.20 |
| 2018-09-30 | 59.91 | $15.77 | 3.80 |
| 2018-06-30 | 43.00 | $15.19 | 2.83 |
| 2018-03-31 | 34.91 | $14.48 | 2.41 |
| 2017-12-31 | 36.26 | $14.20 | 2.55 |
| 2017-09-30 | 31.90 | $14.71 | 2.17 |
| 2017-06-30 | 29.00 | $15.30 | 1.90 |
| 2017-03-31 | 29.85 | $15.27 | 1.96 |
| 2016-12-31 | 36.07 | $15.02 | 2.40 |
| 2016-09-30 | 29.86 | $15.00 | 1.99 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.417B | $1.886B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $84.995B | 10.55 |
| Cencora (COR) | United States | $43.734B | 16.44 |
| DiDi Global (DIDIY) | China | $22.941B | 0.00 |
| Natera (NTRA) | United States | $20.871B | 0.00 |
| ICON (ICLR) | Ireland | $16.879B | 15.03 |
| Viatris (VTRS) | United States | $14.478B | 4.46 |
| Avantor (AVTR) | United States | $14.307B | 21.45 |
| Revvity (RVTY) | United States | $13.453B | 23.37 |
| BioMerieux (BMXMF) | France | $12.659B | 0.00 |
| CochLear (CHEOY) | Australia | $11.807B | 0.00 |
| Solventum (SOLV) | United States | $11.540B | 0.00 |
| Doximity (DOCS) | United States | $10.302B | 60.64 |
| Charles River Laboratories (CRL) | United States | $9.314B | 18.00 |
| HealthEquity (HQY) | United States | $8.212B | 41.20 |
| Sonic Healthcare (SKHHY) | Australia | $8.208B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.322B | 29.43 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.759B | 20.11 |
| Organon (OGN) | United States | $3.719B | 3.75 |
| BrightSpring Health Services (BTSG) | United States | $2.967B | 63.11 |
| Surgery Partners (SGRY) | United States | $2.493B | 28.42 |
| Concentras Parent (CON) | United States | $2.491B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.291B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.069B | 0.00 |
| Premier (PINC) | United States | $2.067B | 10.76 |
| PACS (PACS) | United States | $1.992B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.969B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.730B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
| Teladoc Health (TDOC) | United States | $1.544B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.224B | 11.98 |
| Progyny (PGNY) | United States | $1.208B | 24.47 |
| Embecta (EMBC) | United States | $1.161B | 8.12 |
| CareDx (CDNA) | United States | $1.102B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.090B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.874B | 5.91 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.775B | 0.00 |
| SBC Medicals (SBC) | United States | $0.649B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.492B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
| DocGo (DCGO) | United States | $0.444B | 16.73 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| Enhabit (EHAB) | United States | $0.387B | 33.48 |
| Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.268B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Biodesix (BDSX) | United States | $0.198B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| ModivCare (MODV) | United States | $0.156B | 8.44 |
| MultiPlan (MPLN) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 15.69 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeueHealth (NEUE) | United States | $0.033B | 0.87 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |